Topics
September 2017 | retina Surgery surgical Pearls
ILM Peeling During Diabetic Vitrectomy: When and Why
Surgeons must be aware of their outcomes in deciding how to approach DME surgically.
Timothy G. Murray, MD, FACS
October 20, 2026
EyePoint to Shift Focus, Cut Workforce Following Phase 3 Duravyu Results
October 19, 2026
Second Phase 3 Trial of Duravyu in Wet AMD Misses Primary Endpoint
October 16, 2026
Alvotech and Advanz Pharma Submit European Application for First Proposed Eylea 8 mg Biosimilar
FDA Approves Genentech's Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
